Bring your dosage chart to appointments
Better known to the public by brand names such as Ozempic, Wegovy, Trulicity, Rybelsus, Victoza, Saxenda, and Mounjaro, these glucose-lowering medications, which were initially approved for the treatment of patients with type 2 diabetes, have made headlines recently thanks to their demonstrated effectiveness at treating obesity and helping people with or without diabetes lose weight
Exenatide IR (immediate-release) is given twice daily, while exenatide ER is a once-weekly microsphere formulation
DFO (4060 mg/kg/day) significantly reduces serum transferrin saturation in stroke patients and has a positive effect on patients with moderate to severe ischemic stroke
Gut microbiota, antibiotic therapy and antimicrobial resistance: A narrative review